Press Releases

PTC is committed to serving the interests of all our stakeholders.
Pam & Kelsey
Living with PKU, United States

The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. PTC Therapeutics disavows any obligation to update the information contained in such press releases after the date of their issuance.

May 28, 2020
PTC Therapeutics to Host First Deep Dive Webinar on Bio-e Platform
SOUTH PLAINFIELD, N.J. , May 28, 2020 /PRNewswire/ --  PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it will hold a series of virtual deep dive webinars discussing its therapeutic platforms and programs. The first webinar in the series will discuss its Bio-e platform on Friday, June 5
Read More
May 06, 2020
PTC Therapeutics to Acquire Censa Pharmaceuticals
- Acquisition diversifies and strengthens PTC Therapeutics' rare disorders portfolio - - Compelling Phase 3 ready asset to potentially address unmet need in PKU - SOUTH PLAINFIELD, N.J. , May 6, 2020 /PRNewswire/ --  PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it has entered into an
Read More
Apr 17, 2020
PTC Therapeutics Announces New Leadership Appointments
SOUTH PLAINFIELD, N.J. , April 17, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the appointments of Matthew Klein , M.D., to Chief Development Officer and Eric Pauwels to Chief Business Officer. Dr. Klein will be responsible for the development of our clinical stage
Read More